Home/ Stocks/ JAGX

Jaguar Health, Inc.

JAGX XNAS

$2.56 +0.12 (+4.69%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$2.13M

About Jaguar Health, Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 47 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$20.27M	$8.72M	$-13.60
FY 2025	$11.51M	$-53,997,000	$-22.97
Q3 2025	$3.08M	$-9,648,000	$-6.28
Q2 2025	$2.98M	$-10,560,000	$-10.26

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 12, 2026

Calendar →

TickerDaily Coverage

Why Is Jaguar Health (JAGX) Stock Down 50.6% Today?

Penny Stocks Marcus Rivera · May 4, 2026

Jaguar Health (JAGX) stock tanked 50.6% Monday, plummeting from $6.69 to $3.30 on 221,869...

View All Coverage →

Get JAGX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Jaguar Health, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.